help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, J. R.
Right arrow Articles by Olefsky, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, J. R.
Right arrow Articles by Olefsky, J. M.

Endocrinology, Vol 119, 1786-1792, Copyright © 1986 by Endocrine Society


ARTICLES

Demonstration of insulin receptors and modulation of alkaline phosphatase activity by insulin in rat osteoblastic cells

JR Levy, E Murray, S Manolagas and JM Olefsky

Osteoporosis is a known complication of diabetes mellitus, suggesting a role for insulin in bone homeostasis. We studied insulin receptors and insulin action in the osteoblast-like rat osteogenic sarcoma cell line ROS 17/2.8. These cells share many common features with the osteoblast, such as 1,25-dihydroxyvitamin D3 receptors, PTH receptors, and 1,25- dihydroxyvitamin D3-induced modulation of alkaline phosphatase activity and osteocalcin. Competition binding studies revealed high affinity insulin receptors, with an ED50 for insulin of 1 nM. The receptors were highly specific for insulin, with 60% inhibition of insulin binding by an antireceptor antibody, no competition by epidermal growth factor, and an ED50 of 300 nM for proinsulin. Steady state maximal insulin binding was obtained by 40 min at 37 C, and insulin degradation, as measured by trichloroacetic acid solubility, was 1%/h at 37 C. ROS cells readily internalized insulin, and under steady state binding conditions at 37 C, 56% of the cell-associated radioactivity consisted of intracellular material. Chloroquine (100 microM) inhibited intracellular processing of insulin, leading to a 300% increase in cell- associated insulin by 2 h (37 C). Photoaffinity labeling of the insulin receptor with the photosensitive analog of insulin, B2 (2-nitro-4- azidophenyl-acetyl)des-pheB1-insulin, followed by solubilization and sodium dodecyl sulfate-polyacrylamide gel electrophoresis, revealed specific bands of 125K and 430K mol wt under reducing and nonreducing conditions, respectively. Thus, the structure of insulin receptors in ROS cells appears comparable to that of insulin receptors of known target tissues. Insulin action was also examined. Insulin did not stimulate [2-3H]deoxyglucose uptake or [1-14C]leucine incorporation into protein. In contrast, physiological concentrations of insulin inhibited alkaline phosphatase activity in nonconfluent cells. After exposure to insulin for 24 h, alkaline phosphatase activity was decreased compared to basal by 39.5% and 50% with 5 and 50 ng/ml insulin, respectively. In conclusion, ROS cells bind insulin to specific receptors that are similar to insulin receptors on other target tissues; receptors internalize insulin, which is then processed through a chloroquine-sensitive pathway; insulin does not affect membrane substrate transport; and insulin does inhibit the activity of an enzyme that is important in bone metabolism. ROS cells represent a model for studying insulin effects on bone.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
K. Fulzele, D. J. DiGirolamo, Z. Liu, J. Xu, J. L. Messina, and T. L. Clemens
Disruption of the Insulin-like Growth Factor Type 1 Receptor in Osteoblasts Enhances Insulin Signaling and Action
J. Biol. Chem., August 31, 2007; 282(35): 25649 - 25658.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Irwin, H. V. Lin, K. J. Motyl, and L. R. McCabe
Normal Bone Density Obtained in the Absence of Insulin Receptor Expression in Bone
Endocrinology, December 1, 2006; 147(12): 5760 - 5767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E735 - E745.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. M. Thrailkill, L. Liu, E. C. Wahl, R. C. Bunn, D. S. Perrien, G. E. Cockrell, R. A. Skinner, W. R. Hogue, A. A. Carver, J. L. Fowlkes, et al.
Bone Formation Is Impaired in a Model of Type 1 Diabetes
Diabetes, October 1, 2005; 54(10): 2875 - 2881.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. J. Meier, J. D. Veldhuis, and P. C. Butler
Pulsatile Insulin Secretion Dictates Systemic Insulin Delivery by Regulating Hepatic Insulin Extraction In Humans
Diabetes, June 1, 2005; 54(6): 1649 - 1656.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Chan, M. Lisanti, E Rodriguez-Boulan, and A. Saltiel
Insulin-stimulated release of lipoprotein lipase by metabolism of its phosphatidylinositol anchor
Science, September 23, 1988; 241(4873): 1670 - 1672.
[Abstract] [PDF]


Home page
ScienceHome page
M. Low and A. Saltiel
Structural and functional roles of glycosyl-phosphatidylinositol in membranes
Science, January 15, 1988; 239(4837): 268 - 275.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1986 by The Endocrine Society